Background. Candida pericarditis is a rare medical and surgical emerge
ncy which, unless treated, leads to impaired cardiac function and deat
h. To facilitate early diagnosis, the clinical features of this condit
ion should be identified. Methods. Twenty-five cases of Candida perica
rditis reported in the last 30 years along with 1 new case were review
ed with regard to demographics, precipitating factors, diagnosis, trea
tment, and outcome. Results. The syndrome occurred in immunocompromise
d (73%), antibiotic-treated (62%), or postpericardiotomy (54%) patient
s. The clinical presentation was frequently subtle and nonspecific. Ne
vertheless, unexplained fever, an increasing cardiac shadow on chest r
oentgenogram, or the development of cardiac tamponade may be suggestiv
e. Positive culture for Candida in pericardial fluid or histologic evi
dence of yeast forms in pericardial tissue establishes the diagnosis.
A combination of pericardiocentesis followed by operative drainage and
antifungal agents is the usual treatment. Untreated, Candida pericard
itis is 100% lethal, whereas prompt diagnosis and treatment lead to cu
re (mean follow-up, 19 months). Conclusions. Fever and evolving cardia
c tamponade in immunocompromised or postpericardiotomy patients may be
suggestive of Candida pericarditis; the presence of organisms in peri
cardial fluid is diagnostic. Pericardiocentesis followed by operative
drainage and antifungal agents appears to be the treatment that is mos
t likely to be curative. (C) 1997 by The Society of Thoracic Surgeons.